nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—Angiitis necrotising—Hydrochlorothiazide—nephrolithiasis	0.0593	0.082	CcSEcCtD
Prednisone—Erythema facial—Hydrochlorothiazide—nephrolithiasis	0.0593	0.082	CcSEcCtD
Prednisone—Vasculitis necrotising—Hydrochlorothiazide—nephrolithiasis	0.0517	0.0715	CcSEcCtD
Prednisone—Blood potassium increased—Hydrochlorothiazide—nephrolithiasis	0.0359	0.0496	CcSEcCtD
Prednisone—HSD11B1—renal system—nephrolithiasis	0.0293	0.137	CbGeAlD
Prednisone—CYP2C19—urine—nephrolithiasis	0.029	0.136	CbGeAlD
Prednisone—HSD11B1—kidney—nephrolithiasis	0.0283	0.132	CbGeAlD
Prednisone—Gastric irritation—Hydrochlorothiazide—nephrolithiasis	0.0279	0.0386	CcSEcCtD
Prednisone—HSD11B1—cortex of kidney—nephrolithiasis	0.0276	0.129	CbGeAlD
Prednisone—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.0246	0.0341	CcSEcCtD
Prednisone—Trauma—Hydrochlorothiazide—nephrolithiasis	0.0227	0.0315	CcSEcCtD
Prednisone—NR3C1—urine—nephrolithiasis	0.0227	0.106	CbGeAlD
Prednisone—Epigastric discomfort—Hydrochlorothiazide—nephrolithiasis	0.0206	0.0285	CcSEcCtD
Prednisone—CYP3A4—urine—nephrolithiasis	0.0171	0.0802	CbGeAlD
Prednisone—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0162	0.0224	CcSEcCtD
Prednisone—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0191	CcSEcCtD
Prednisone—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0185	CcSEcCtD
Prednisone—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0123	0.193	CbGpPWpGaD
Prednisone—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0158	CcSEcCtD
Prednisone—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0153	CcSEcCtD
Prednisone—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00989	0.0137	CcSEcCtD
Prednisone—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00979	0.0135	CcSEcCtD
Prednisone—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00964	0.0133	CcSEcCtD
Prednisone—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00904	0.0125	CcSEcCtD
Prednisone—SLCO1A2—renal system—nephrolithiasis	0.00887	0.0414	CbGeAlD
Prednisone—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00879	0.0122	CcSEcCtD
Prednisone—SLCO1A2—kidney—nephrolithiasis	0.00857	0.0401	CbGeAlD
Prednisone—Injury—Hydrochlorothiazide—nephrolithiasis	0.00855	0.0118	CcSEcCtD
Prednisone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00836	0.0116	CcSEcCtD
Prednisone—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00815	0.0113	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00786	0.0109	CcSEcCtD
Prednisone—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0107	CcSEcCtD
Prednisone—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00759	0.0105	CcSEcCtD
Prednisone—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00744	0.0103	CcSEcCtD
Prednisone—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0072	0.00997	CcSEcCtD
Prednisone—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00715	0.0099	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00693	0.00959	CcSEcCtD
Prednisone—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00693	0.00959	CcSEcCtD
Prednisone—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00684	0.00946	CcSEcCtD
Prednisone—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00666	0.00921	CcSEcCtD
Prednisone—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00635	0.00879	CcSEcCtD
Prednisone—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00626	0.00866	CcSEcCtD
Prednisone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00618	0.00855	CcSEcCtD
Prednisone—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00613	0.00848	CcSEcCtD
Prednisone—NR3C1—nephron tubule—nephrolithiasis	0.0061	0.0285	CbGeAlD
Prednisone—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00597	0.00826	CcSEcCtD
Prednisone—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00594	0.00821	CcSEcCtD
Prednisone—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00594	0.00821	CcSEcCtD
Prednisone—NR3C1—renal system—nephrolithiasis	0.00555	0.0259	CbGeAlD
Prednisone—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00553	0.00766	CcSEcCtD
Prednisone—NR3C1—kidney—nephrolithiasis	0.00536	0.0251	CbGeAlD
Prednisone—NR3C1—cortex of kidney—nephrolithiasis	0.00522	0.0244	CbGeAlD
Prednisone—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00698	CcSEcCtD
Prednisone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.00489	0.0771	CbGpPWpGaD
Prednisone—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00486	0.00672	CcSEcCtD
Prednisone—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00665	CcSEcCtD
Prednisone—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00655	CcSEcCtD
Prednisone—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00446	0.00617	CcSEcCtD
Prednisone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00608	CcSEcCtD
Prednisone—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00437	0.00605	CcSEcCtD
Prednisone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00435	0.00602	CcSEcCtD
Prednisone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00598	CcSEcCtD
Prednisone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00427	0.00591	CcSEcCtD
Prednisone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00588	CcSEcCtD
Prednisone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00424	0.00587	CcSEcCtD
Prednisone—CYP3A4—renal system—nephrolithiasis	0.0042	0.0196	CbGeAlD
Prednisone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00576	CcSEcCtD
Prednisone—CYP3A4—kidney—nephrolithiasis	0.00406	0.019	CbGeAlD
Prednisone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00403	0.00558	CcSEcCtD
Prednisone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00403	0.00558	CcSEcCtD
Prednisone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00556	CcSEcCtD
Prednisone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00398	0.00551	CcSEcCtD
Prednisone—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00534	CcSEcCtD
Prednisone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00534	CcSEcCtD
Prednisone—Shock—Hydrochlorothiazide—nephrolithiasis	0.0038	0.00526	CcSEcCtD
Prednisone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00377	0.00522	CcSEcCtD
Prednisone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00517	CcSEcCtD
Prednisone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00368	0.00509	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00352	0.00487	CcSEcCtD
Prednisone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00349	0.00483	CcSEcCtD
Prednisone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00347	0.0048	CcSEcCtD
Prednisone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0034	0.0047	CcSEcCtD
Prednisone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00336	0.00465	CcSEcCtD
Prednisone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00461	CcSEcCtD
Prednisone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00457	CcSEcCtD
Prednisone—ABCB1—nephron tubule—nephrolithiasis	0.00327	0.0153	CbGeAlD
Prednisone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00318	0.0044	CcSEcCtD
Prednisone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00437	CcSEcCtD
Prednisone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00307	0.00425	CcSEcCtD
Prednisone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00422	CcSEcCtD
Prednisone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00422	CcSEcCtD
Prednisone—ABCB1—renal system—nephrolithiasis	0.00297	0.0139	CbGeAlD
Prednisone—ABCB1—kidney—nephrolithiasis	0.00287	0.0134	CbGeAlD
Prednisone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00394	CcSEcCtD
Prednisone—ABCB1—cortex of kidney—nephrolithiasis	0.0028	0.0131	CbGeAlD
Prednisone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00383	CcSEcCtD
Prednisone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00378	CcSEcCtD
Prednisone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00366	CcSEcCtD
Prednisone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00353	CcSEcCtD
Prednisone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00246	0.0034	CcSEcCtD
Prednisone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00337	CcSEcCtD
Prednisone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00337	CcSEcCtD
Prednisone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00242	0.00335	CcSEcCtD
Prednisone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00317	CcSEcCtD
Prednisone—HSD11B1—Metabolism—GRHPR—nephrolithiasis	0.00192	0.0303	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00173	0.0273	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—AGXT—nephrolithiasis	0.00171	0.027	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00158	0.025	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00158	0.025	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—SLC26A1—nephrolithiasis	0.00146	0.023	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—APRT—nephrolithiasis	0.00146	0.023	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0012	0.0189	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0012	0.0189	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00112	0.0176	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00112	0.0176	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—AQP1—nephrolithiasis	0.00104	0.0164	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000994	0.0157	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000987	0.0156	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000987	0.0156	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—CHRM3—nephrolithiasis	0.000939	0.0148	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000879	0.0139	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000846	0.0133	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000804	0.0127	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000804	0.0127	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000773	0.0122	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000773	0.0122	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000681	0.0107	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00061	0.00962	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00061	0.00962	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000586	0.00925	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000586	0.00925	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000567	0.00894	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000567	0.00894	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000553	0.00873	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000545	0.0086	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000545	0.0086	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000505	0.00797	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000505	0.00797	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000486	0.00766	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000482	0.00761	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000482	0.00761	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00043	0.00678	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000422	0.00666	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000422	0.00666	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000409	0.00646	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000404	0.00637	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000393	0.0062	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000393	0.0062	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000376	0.00594	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GRHPR—nephrolithiasis	0.00035	0.00553	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000344	0.00543	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000344	0.00543	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AGXT—nephrolithiasis	0.000312	0.00492	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000298	0.0047	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000298	0.0047	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.000285	0.0045	CbGpPWpGaD
Prednisone—ALB—Hemostasis—DGKH—nephrolithiasis	0.000285	0.0045	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000277	0.00437	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000277	0.00437	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—APRT—nephrolithiasis	0.000265	0.00419	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SLC26A1—nephrolithiasis	0.000265	0.00419	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000261	0.00412	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000261	0.00412	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000247	0.00389	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000247	0.00389	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000243	0.00383	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000243	0.00383	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000216	0.00341	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000216	0.00341	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000197	0.00311	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AQP1—nephrolithiasis	0.000189	0.00298	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000173	0.00273	CbGpPWpGaD
Prednisone—ALB—Metabolism—GRHPR—nephrolithiasis	0.000171	0.0027	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CHRM3—nephrolithiasis	0.000171	0.0027	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000154	0.00242	CbGpPWpGaD
Prednisone—ALB—Metabolism—AGXT—nephrolithiasis	0.000153	0.00241	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.00015	0.00237	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000137	0.00216	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000134	0.00211	CbGpPWpGaD
Prednisone—ALB—Metabolism—APRT—nephrolithiasis	0.00013	0.00205	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC26A1—nephrolithiasis	0.00013	0.00205	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000116	0.00184	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000116	0.00184	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000114	0.00179	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—APRT—nephrolithiasis	0.000114	0.00179	CbGpPWpGaD
Prednisone—ALB—Metabolism—AQP1—nephrolithiasis	9.24e-05	0.00146	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GRHPR—nephrolithiasis	9.24e-05	0.00146	CbGpPWpGaD
Prednisone—ALB—Metabolism—CHRM3—nephrolithiasis	8.36e-05	0.00132	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AQP1—nephrolithiasis	8.29e-05	0.00131	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AGXT—nephrolithiasis	8.23e-05	0.0013	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AQP1—nephrolithiasis	8.1e-05	0.00128	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CHRM3—nephrolithiasis	7.5e-05	0.00118	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CHRM3—nephrolithiasis	7.32e-05	0.00116	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—APRT—nephrolithiasis	7e-05	0.0011	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	7e-05	0.0011	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AQP1—nephrolithiasis	4.99e-05	0.000787	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CHRM3—nephrolithiasis	4.51e-05	0.000712	CbGpPWpGaD
